glp-1 dual agonist Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care The Emerging Role of Dual
Description
Am J Pathol (2005) 166(2):43342

Sci Data

Latorraca, N

Call your healthcare provider right away if you experience: Persistent vomiting Severe abdominal pain, especially if it radiates to the back Signs of dehydration, such as dizziness, very dark urine, weakness, or inability to keep fluids down Severe constipation or no bowel movement with pain and bloating Symptoms of gallbladder problems, such as upper right abdominal pain, fever, yellowing of the skin or eyes, or clay-colored stools Nausea that does not improve or prevents you from eating enough Nutrition support is powerful, but it does not replace medical evaluation when symptoms are severe

prices are significantly higher than in high-income European countries

GLP-1 drugs are indicated for patients with obesity, i.e
